William M Greenberg Selected Research

Levomilnacipran

3/2016	Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.
10/2015	Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects.
9/2015	Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition.
4/2015	Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials.
1/2015	Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.
1/2015	Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans.
7/2014	Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials.
5/2014	Effect of hepatic impairment on the pharmacokinetics of levomilnacipran following a single oral dose of a levomilnacipran extended-release capsule in human participants.
2/2014	A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder.
1/2014	Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William M Greenberg Research Topics

Disease

14	Major Depressive Disorder (Major Depressive Disorders) 03/2016 - 03/2013
5	Schizophrenia (Dementia Praecox) 01/2017 - 01/2007
3	Nausea 02/2014 - 01/2014
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2017 - 01/2007
2	Vomiting 03/2015 - 02/2014
2	Mania (Manias) 03/2015 - 01/2007
2	Hyperhidrosis 02/2014 - 01/2014
2	Constipation 02/2014 - 01/2014
2	Dizziness (Lightheadedness) 02/2014 - 01/2014
1	Fatigue 03/2016
1	Medically Unexplained Symptoms 03/2016
1	Psychotic Disorders (Schizoaffective Disorder) 12/2015
1	Dyspepsia (Indigestion) 03/2015
1	Tremor (Tremors) 03/2015
1	Basal Ganglia Diseases (Basal Ganglia Disease) 03/2015
1	Psychomotor Agitation (Akathisia) 03/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2014
1	Tachycardia (Tachyarrhythmias) 02/2014
1	Hypertension (High Blood Pressure) 02/2014
1	Erectile Dysfunction 01/2014
1	Headache (Headaches) 01/2014
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 03/2009
1	Sleepiness 01/2007
1	Orthostatic Hypotension (Postural Hypotension) 01/2007
1	Weight Gain 01/2007
1	Atrophy 01/2003

Drug/Important Bio-Agent (IBA)

14	LevomilnacipranIBA 03/2016 - 03/2013
6	Serotonin (5 Hydroxytryptamine)IBA 10/2015 - 10/2013
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2015 - 10/2013
3	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 01/2007
2	cariprazineIBA 01/2017 - 03/2015
1	Lurasidone Hydrochloride FDA Link 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Paliperidone Palmitate FDA Link 12/2015
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2009
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2008
1	Triglycerides (Triacylglycerol)IBA 01/2007
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2007
1	Olanzapine (Zyprexa)FDA Link 01/2007
1	Chlorpromazine (Thorazine)FDA Link 01/2007
1	CholesterolIBA 01/2007
1	Haloperidol (Haldol)FDA LinkGeneric 01/2007
1	Mesylates (Mesylate)IBA 01/2007
1	ProlactinIBA 01/2007
1	ziprasidone (Geodon)FDA Link 01/2007
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2007
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2007
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2003

Therapy/Procedure

2	Secondary Prevention 12/2015 - 01/2014
1	Injections 12/2015
1	Glycemic Control 01/2007